Megna Michael R bought KNSA
September 3, 2025 · Form 4 insider transaction
Megna Michael R bought 11,000 shares of Kiniksa Pharmaceuticals International, plc at $17.92 per share, a transaction worth $197.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,000
Price
$17.92
Total value
$197.1K
InsiderMegna Michael R
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateSeptember 3, 2025
Filing dateSeptember 3, 2025
Shares owned after49,011
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024.